SG11201809672YA - Process For Preparing 5-Hydroxyalkyl-Substituted 1-Phenyl-1,2,4-Triazole Derivatives - Google Patents
Process For Preparing 5-Hydroxyalkyl-Substituted 1-Phenyl-1,2,4-Triazole DerivativesInfo
- Publication number
- SG11201809672YA SG11201809672YA SG11201809672YA SG11201809672YA SG11201809672YA SG 11201809672Y A SG11201809672Y A SG 11201809672YA SG 11201809672Y A SG11201809672Y A SG 11201809672YA SG 11201809672Y A SG11201809672Y A SG 11201809672YA SG 11201809672Y A SG11201809672Y A SG 11201809672YA
- Authority
- SG
- Singapore
- Prior art keywords
- hydroxyalkyl
- preparing
- triazole derivatives
- phenyl
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D249/12—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Process for preparing 5-hydroxyalkyl-substituted 1-phenyl-1,2,4-triazole derivatives The present application relates to a novel and improved process for preparing 5- (hydroxyalkyl)-1-pheny1-1,2,4-triazole derivatives of the formula (I) HO OHO,,F / N—N N R IAIF 1B d ilk R CI (I) 5 in which RIA and RIB are independently selected from the group consisting of hydrogen, fluorine, chlorine, methyl, monofluoromethyl, difluoromethyl, trifluoromethyl, ethyl, methoxy, difluoromethoxy and trifluoromethoxy, to novel precursors for preparation thereof, and to the preparation and use of the crystalline 10 polymorph I of (5-(4-chloropheny1)-24(1-(3-chloropheny1)-5-[(1 S)- 1-hydroxyethy1]-1H- 1 ,2,4-triazol-3 -yl}methyl)-4-[(28)-3,3,3 -trifluoro-2-hydroxypropy1]-2,4-dihydro-3 H- 1,2,4 - triazol-3 -one of the formula (I-A-1). No suitable figure
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP16168169 | 2016-05-03 | ||
EP16168172 | 2016-05-03 | ||
EP16168165 | 2016-05-03 | ||
EP16168166 | 2016-05-03 | ||
EP16168163 | 2016-05-03 | ||
EP17160086 | 2017-03-09 | ||
PCT/EP2017/060367 WO2017191104A1 (en) | 2016-05-03 | 2017-05-02 | Method for producing 5-hydroxyalkyl-substituted 1-phenyl-1,2,4- triazole derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201809672YA true SG11201809672YA (en) | 2018-11-29 |
Family
ID=58633014
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201809672YA SG11201809672YA (en) | 2016-05-03 | 2017-05-02 | Process For Preparing 5-Hydroxyalkyl-Substituted 1-Phenyl-1,2,4-Triazole Derivatives |
Country Status (18)
Country | Link |
---|---|
US (2) | US10703742B2 (en) |
EP (1) | EP3452467A1 (en) |
JP (2) | JP6921863B2 (en) |
KR (1) | KR20190003536A (en) |
CN (2) | CN109071500B (en) |
AU (2) | AU2017259872B2 (en) |
BR (1) | BR112018072528A2 (en) |
CA (1) | CA3022789A1 (en) |
CL (1) | CL2018003107A1 (en) |
CO (1) | CO2018011948A2 (en) |
IL (1) | IL262534B (en) |
MX (2) | MX2018013336A (en) |
PE (1) | PE20190202A1 (en) |
RU (1) | RU2742885C2 (en) |
SG (1) | SG11201809672YA (en) |
TW (1) | TWI755393B (en) |
UY (1) | UY37222A (en) |
WO (1) | WO2017191104A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9988367B2 (en) * | 2016-05-03 | 2018-06-05 | Bayer Pharma Aktiengesellschaft | Amide-substituted pyridinyltriazole derivatives and uses thereof |
WO2017191104A1 (en) * | 2016-05-03 | 2017-11-09 | Bayer Pharma Aktiengesellschaft | Method for producing 5-hydroxyalkyl-substituted 1-phenyl-1,2,4- triazole derivatives |
EP3452457B1 (en) * | 2016-05-03 | 2020-03-18 | Bayer Pharma Aktiengesellschaft | Oxoalkyl-substituted phenyltriazole derivatives and uses thereof |
WO2021259852A1 (en) | 2020-06-25 | 2021-12-30 | Bayer Aktiengesellschaft | Process for preparing 5-(alkoxycarbonyl)-and 5-(carboxamide)-1-aryl-1,2,4-triazole derivatives |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI490212B (en) * | 2006-05-25 | 2015-07-01 | Synta Pharmaceuticals Corp | Triazole compounds that modulate hsp90 activity |
JP2012503005A (en) * | 2008-09-19 | 2012-02-02 | インスティテュート フォア ワンワールド ヘルス | Compounds, compositions and methods comprising imidazole derivatives and triazole derivatives. |
DE102010001064A1 (en) | 2009-03-18 | 2010-09-23 | Bayer Schering Pharma Aktiengesellschaft | Substituted 2-acetamido-5-aryl-1,2,4-triazolones and their use |
BR112012021498B8 (en) * | 2010-02-27 | 2020-04-14 | Bayer Ip Gmbh | Bisaryl-linked aryltriazolones and their use |
AU2013258107B2 (en) * | 2012-05-08 | 2017-06-22 | Bayer Pharma Aktiengesellschaft | Method for the preparation of triazole compounds |
PE20170945A1 (en) | 2014-11-03 | 2017-07-13 | Bayer Pharma AG | HYDROXYALKYL SUBSTITUTED PHENYLTRIAZOLE DERIVATIVES AND THEIR USES |
US9988367B2 (en) * | 2016-05-03 | 2018-06-05 | Bayer Pharma Aktiengesellschaft | Amide-substituted pyridinyltriazole derivatives and uses thereof |
WO2017191104A1 (en) * | 2016-05-03 | 2017-11-09 | Bayer Pharma Aktiengesellschaft | Method for producing 5-hydroxyalkyl-substituted 1-phenyl-1,2,4- triazole derivatives |
EP3452457B1 (en) * | 2016-05-03 | 2020-03-18 | Bayer Pharma Aktiengesellschaft | Oxoalkyl-substituted phenyltriazole derivatives and uses thereof |
-
2017
- 2017-05-02 WO PCT/EP2017/060367 patent/WO2017191104A1/en active Application Filing
- 2017-05-02 US US16/098,238 patent/US10703742B2/en not_active Expired - Fee Related
- 2017-05-02 KR KR1020187031568A patent/KR20190003536A/en not_active Application Discontinuation
- 2017-05-02 AU AU2017259872A patent/AU2017259872B2/en not_active Ceased
- 2017-05-02 MX MX2018013336A patent/MX2018013336A/en unknown
- 2017-05-02 TW TW106114435A patent/TWI755393B/en not_active IP Right Cessation
- 2017-05-02 MX MX2020010365A patent/MX2020010365A/en unknown
- 2017-05-02 EP EP17719636.7A patent/EP3452467A1/en not_active Withdrawn
- 2017-05-02 BR BR112018072528-5A patent/BR112018072528A2/en active Search and Examination
- 2017-05-02 SG SG11201809672YA patent/SG11201809672YA/en unknown
- 2017-05-02 JP JP2018557408A patent/JP6921863B2/en active Active
- 2017-05-02 CN CN201780027607.0A patent/CN109071500B/en not_active Expired - Fee Related
- 2017-05-02 RU RU2018142264A patent/RU2742885C2/en active
- 2017-05-02 CA CA3022789A patent/CA3022789A1/en active Pending
- 2017-05-02 UY UY0001037222A patent/UY37222A/en not_active Application Discontinuation
- 2017-05-02 PE PE2018002254A patent/PE20190202A1/en unknown
- 2017-05-02 CN CN202110424553.XA patent/CN113105403A/en active Pending
-
2018
- 2018-10-23 IL IL262534A patent/IL262534B/en active IP Right Grant
- 2018-10-31 CL CL2018003107A patent/CL2018003107A1/en unknown
- 2018-11-02 CO CONC2018/0011948A patent/CO2018011948A2/en unknown
-
2020
- 2020-05-21 US US16/880,933 patent/US20200299271A1/en not_active Abandoned
-
2021
- 2021-06-14 JP JP2021098486A patent/JP2021143193A/en not_active Withdrawn
- 2021-09-22 AU AU2021236502A patent/AU2021236502A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
TWI755393B (en) | 2022-02-21 |
WO2017191104A1 (en) | 2017-11-09 |
UY37222A (en) | 2017-11-30 |
JP6921863B2 (en) | 2021-08-18 |
CN113105403A (en) | 2021-07-13 |
TW201815782A (en) | 2018-05-01 |
MX2018013336A (en) | 2019-05-09 |
US20200299271A1 (en) | 2020-09-24 |
IL262534A (en) | 2018-12-31 |
CO2018011948A2 (en) | 2018-11-22 |
AU2017259872A1 (en) | 2018-11-22 |
EP3452467A1 (en) | 2019-03-13 |
PE20190202A1 (en) | 2019-02-05 |
CL2018003107A1 (en) | 2019-02-22 |
MX2020010365A (en) | 2022-04-06 |
RU2018142264A (en) | 2020-06-03 |
CN109071500B (en) | 2021-05-18 |
JP2021143193A (en) | 2021-09-24 |
CN109071500A (en) | 2018-12-21 |
US20190144431A1 (en) | 2019-05-16 |
CA3022789A1 (en) | 2017-11-09 |
RU2742885C2 (en) | 2021-02-11 |
KR20190003536A (en) | 2019-01-09 |
US10703742B2 (en) | 2020-07-07 |
AU2017259872B2 (en) | 2021-06-24 |
JP2019514948A (en) | 2019-06-06 |
AU2021236502A1 (en) | 2021-10-21 |
BR112018072528A2 (en) | 2019-03-26 |
RU2018142264A3 (en) | 2020-08-19 |
IL262534B (en) | 2021-04-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG11201809672YA (en) | Process For Preparing 5-Hydroxyalkyl-Substituted 1-Phenyl-1,2,4-Triazole Derivatives | |
IL281196B (en) | Process for the preparation of methyl 6-(2,4-dichlorophenyl)-5-[4-[(3s)-1-(3 fluoropropyl)pyrrolidin-3-yl]oxyphenyl]-8,9-dihydro-7h-benzo[7]annulene-2-carboxylate | |
MX2012007925A (en) | Polymorphic, crystalline and mesophase forms of sodium 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4h-1,2,4-triazol-3- ylthio)acetate, and uses thereof. | |
CL2014000384A1 (en) | Fungicidal compounds of 1- (2- (2-halo-4- (4-halogen-phenoxy) -phenyl) -2-alkoxy-2-alkynyl / alkenyl-ethyl) -1h- (1,2,4) substituted triazole ; process for preparing said compounds; agrochemical compositions | |
WO2013042138A3 (en) | Process for preparation of triazole antifungal drug, its intermediates and polymorphs thereof | |
FI119548B (en) | Apolipoprotein B synthesis inhibitors | |
JP2018519323A5 (en) | ||
TNSN07475A1 (en) | SUBSTITUTED ARYLPYRAZOLES FOR USE AGAINST PARASITES | |
US20230025510A1 (en) | Biaryl ether-type quinazoline derivatives | |
NZ601316A (en) | 4-[-2-[[5-methyl-1-(2-naphtalenyl)-1h-pyrazol-3-yl]oxy]ethyl]morpholine hydrochloride polymorphs and solvates | |
PH12015502088A1 (en) | Novel compositions and processes for preparing 5-amino or substituted amino 1,2,3-triazoles and triazole orotate formulations | |
JP2017512803A5 (en) | ||
JP2018511613A5 (en) | ||
WO2007013096A8 (en) | Improved process for the preparation of 2r, 3s-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1h-1,2,4-triazol-1-yl) butan-2-ol (voriconazole) | |
MY184577A (en) | Method for the preparation of triazole compounds | |
NI202000030A (en) | PROPHARMACS OF SUBSTITUTED TRIAZOLE DERIVATIVES AND THEIR USES | |
EP3233824A4 (en) | (s)-n-(3-(6-isopropoxypyridin-3-yl)-1h-indazol-5-yl)-1-(2-(4-(4-(1-methyl-1h-1,2,4-triazol-3-yl)phenyl)-3,6-dihydropyridin-1(2h)-yl)-2-oxoethyl)-3- (methylthio)pyrrolidine-3-carboxamide compositions for pharmaceutical preparations | |
EP0871626A1 (en) | Novel triazolones as apolipoprotein-b synthesis inhibitors | |
JP2016520636A5 (en) | ||
EP3233079A4 (en) | (s)-n-(3-(6-isopropoxypyridin-3-yl)-1h-indazol-5-yl)-1-(2-(4-(4-(1-methyl-1h-1,2,4-triazol-3-yl)phenyl)-3,6-dihydropyridin-1(2h)-yl)-2-oxoethyl)-3-(methylthio)pyrrolidine-3-carboxamide compositions for pharmaceutical preparations | |
IL291569A (en) | Process for the production of 5-(4-((2 s,5 s)-5-(4-chlorobenzyl)-2-methylmorpholino)piperidin-1-yl)-1 h-1,2,4-triazol-3-amine | |
AR076372A1 (en) | DERIVATIVES OF ETIL-TIOTRIAZOL, PHARMACEUTICAL COMPOSITIONS THAT UNDERSTAND THEM, INTERMEDIARIES FOR THEIR SYNTHESIS AND THEIR USE IN THE TREATMENT OF MGLUR5-mediated DISORDERS | |
JP2017532300A5 (en) | ||
IL249496B (en) | Improved process for preparation of 4-(1-(4-(perfluoroethoxy)phenyl)-1h-1,2,4-triazol-3-yl)benzoyl azide | |
ZA202212697B (en) | Process for the preparation salts of triazole compounds |